Trastuzumab-rezetecan
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Trastuzumab-rezetecan in HER2-Expressing Breast Cancer (NCT07358182) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2025-06-01 |
Track Trastuzumab-rezetecan automatically
Every clearance here is in the API, with alerts when new ones post.